Carfilzomib 56 mg/m2 twice-weekly in combination with dexamethasone and daratumumab (KdD) versus daratumumab in combination with bortezomib and dexamethasone (DVd): a matching-adjusted indirect treatment comparison

Katja Weisel, Ajay K. Nooka, Evangelos Terpos, Andrew Spencer, Hartmut Goldschmidt, Franziska Dirnberger, Lucy DeCosta, Akeem Yusuf, Shaji Kumar

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Carfilzomib 56 mg/m2 twice-weekly in combination with dexamethasone and daratumumab (KdD) versus daratumumab in combination with bortezomib and dexamethasone (DVd): a matching-adjusted indirect treatment comparison'. Together they form a unique fingerprint.

Medicine & Life Sciences